APOE and Alzheimer disease: The PHS showed substantial improvement over APOE in predicting the age of AD onset and was associated with biomarkers of AD, including MRI-based hippocampal volume loss and cognitive impairment (Desikan et al., 2017; Kauppi et al., 2018).